Thus, inhibition of SphK1 activity with corresponding decrease of S1P levels induced apoptosis in acute myeloid leukemia (AML) cells (43, 44), and diminished in vivo cell growth of ovarian cancer (45). This evidence concerns the gene SPHK1 and ovarian carcinoma.